Glenmark Pharmaceuticals gains on plan to launch over 10 products in FY16

26 Aug 2015 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 1189.30, up by 1.25 points or 0.11% from its previous closing of Rs. 1188.05 on the BSE.

The scrip opened at Rs. 1188.05 and has touched a high and low of Rs. 1205.10 and Rs. 1156.55 respectively. So far 24993 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1261.95 on 21-Aug-2015 and a 52 week low of Rs. 677.85 on 26-Sep-2014.

Last one week high and low of the scrip stood at Rs. 1261.95 and Rs. 1076.60 respectively. The current market cap of the company is Rs. 33459.49 crore.

The promoters holding in the company stood at 46.44% while Institutions and Non-Institutions held 42.70% and 10.86% respectively.

Glenmark Pharmaceuticals (GPL) is planning to launch 10-12 new products in the domestic market during the current financial year (2015-16) and hopes to report a growth of 18-20 percent. The company wants to increase its focus on the Indian market across four key areas, including dermatology, diabetes, cardiology and respiratory segments. The company derives about 26% of its revenues from the India, which is its second largest market.

GPL is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. It is ranked among the top 80 Pharma & Biotech companies of the world in terms of revenues. (SCRIP 100 Rankings published in the year 2014). Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).

Glenmark Pharma Share Price

2022.90 -13.00 (-0.64%)
01-Jan-2026 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.40
Dr. Reddys Lab 1254.60
Cipla 1504.25
Zydus Lifesciences 910.05
Lupin 2084.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×